| NO. | Product Name | CAS NO. | Applicable symptoms | license number |
| 1 | Levobupivacaine HCl | 27262-47-1 | Anesthetic | Y20190021493 |
| 2 | Vardenafil HCl | 224785-90-4 | Treatment of ED | Y20180001528 |
| 3 | Sinacaside HCl | 1025064-33-8 | Treatment of chronic kidney disease (CKD) | Y20180000458 |
| 4 | Dapoxetine HCl | 129938-20-1 | Anti-premature ejaculation | Y20180001416 |
| 5 | Rosuvastatin Calcium | 147098-20-2 | Hypolipidemic | National Pharmaceutical Standard H20090155 |
| 6 | Febuxostat | 144060-53-7 | Anti-gout | Y20180000440 |
| 7 | Parecoxib Sodium | 198470-85-8 | Analgesic | Y20190000999 |
| 8 | Desloratadine | 100643-71-8 | anti-allergy | Y20180000860 |
| 9 | Apixaban | 503612-47-3 | Antithrombotic | Y20180000609 |
| 10 | Lacosamide | 175481-36-4 | Antiepileptic | Y20190001000 |
| 11 | Prucalopride Succinate | 179474-85-2 | Treat constipation | Y20180000320 |
| 12 | Etoricoxib | 202409-33-4 | Treatment of arthritis | Y20180001167 |
| 13 | Mirabegron | 223673-61-8 | Treatment of overactive bladder | Y20180001417 |
| 14 | Atomoxetine Hcl | 82248-59-7 | Treating children with ADHD | Y20180001108 |
| 15 | Erlotinib | 183321-74-6 | Anticancer drugs | Y20180001037 |
| 16 | Gefitinib | 184475-35-2 | Anticancer drugs | Y20180001109 |
| 17 | Sorafenib tosylate | 475207-59-1 | Anticancer drugs | Y20180000277 |
| 18 | Vildagliptin | 274901-16-5 | Hypoglycemic | Y20180000901 |
| 19 | Celecoxib | 169590-42-5 | Analgesic | Y20180000610 |
| 20 | Ezetimibe | 163222-33-1 | Hypolipidemic | Y20180001036 |
| 21 | Sitagliptin phosphate | 486460-32-6 | Hypoglycemic | Y20190021505 |
| 22 | Sunitinib Malate | 341031-54-7 | Anticancer drugs | Y20190000281 |
| 23 | Pranoprofen | 52549-17-4 | Treatment of blepharitis, conjunctivitis, keratitis, scleritis | Y20190021277 |
| 24 | Varenicline Tartrate | 375815-87-5 | Quit smoking | Y20190021278 |
简体中文
简体中文
